MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Management of Dystonia in Europe from Patients’ Experience

M. Relja, V. Miletic (Zagreb, Croatia)

Meeting: MDS Virtual Congress 2020

Abstract Number: 177

Keywords: Dystonia: Clinical features

Category: Education in Movement Disorders

Objective: To investigate management of dystonia in Europe from patients’ experience obtained from on-line survey.

Background: We have reported a lack of specific training in dystonia by general neurologist (GN), family doctors (GP) and health professionals in a study performed by the European Network for the Study of Dystonia Syndromes (Valades et al. Eur J Neurol 2016.). But there no data of care from patients’ experience.

Method: The validated on-line questionnaire (available in 24 languages) was distributed to dystonia patients in Europe through dystonia website. Questionnaire was divided into 3 parts (1. General questions: gender, age, etc., 2. Specific questions: type of dystonia, time to correct diagnosis, etc., 3. Therapy, side effects, quality of life, etc.). Data were collected from 2017-2019.

Results: A total of 3000 questionnaires were received from 30 European countries. Women outnumbered men by about 3 to 1, while cervical dystonia was the most common type (48%). Only 29% of patients obtained a correct diagnosis within one year after first symptoms, while 14% waited longer than 10 years. Consequently,
only 25% of patients received treatment within one year, while 16% waited 5-10 years. In only 16% of patients GP recognized the symptoms during first visit and referred patients to appropriate specialist. Botulinum toxin was the most common type of treatment (45% of patients), followed by drugs (25%) and deep brain stimulation (19%). But only 30% of patients are satisfied with treatment. Dystonia affects working status in 59% of patients, social life 55% and every aspects of their life in 34% of patients.

Conclusion: Data obtained from first European on-line survey in dystonia patients showed a long interval to diagnosis and treatment and consequently pure quality of life (QoL). This is compatible with the limited knowledge of dystonia and lack of training of GN and GP retrieved from a previous study among neurologist. Recognizing dystonia is important for patients’ treatment and QoL.
(Management and quality of life of dystonia patients in Europe: a survey towards care from a patients’ experience.  Relja et al. EAN Oslo June 29th-July 2nd 2019.)

To cite this abstract in AMA style:

M. Relja, V. Miletic. Management of Dystonia in Europe from Patients’ Experience [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/management-of-dystonia-in-europe-from-patients-experience/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/management-of-dystonia-in-europe-from-patients-experience/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley